Connection
Daniel Bowles to Phenylthiohydantoin
This is a "connection" page, showing publications Daniel Bowles has written about Phenylthiohydantoin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.196 |
|
|
|
-
Ho AL, Foster NR, Zoroufy AJ, Campbell JD, Worden F, Price K, Adkins D, Bowles DW, Kang H, Burtness B, Sherman E, Morton R, Morris LGT, Nadeem Z, Katabi N, Munster P, Schwartz GK. Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). J Clin Oncol. 2022 12 20; 40(36):4240-4249.
Score: 0.196